Citations (179)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, Alexander Steinle, Jennifer S. Michaelson & Patrick A. Baeuerle. (2023) Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors. mAbs 15:1.
Read now
Read now
Sean M. Peterson, Catherine J. Hutchings, Cameron F. Hu, Melina Mathur, Janelle W. Salameh, Fumiko Axelrod & Aaron K. Sato. (2023) Discovery and design of G protein-coupled receptor targeting antibodies. Expert Opinion on Drug Discovery 18:4, pages 417-428.
Read now
Read now
Anurag Rathore & Himanshu Malani. (2022) Need for a risk-based control strategy for managing glycosylation profile for biosimilar products. Expert Opinion on Biological Therapy 22:2, pages 123-131.
Read now
Read now
Dhuha H Nawab. (2021) Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects. Human Vaccines & Immunotherapeutics 17:12, pages 5532-5545.
Read now
Read now
Steffen Lippold, Simone Nicolardi, Elena Domínguez-Vega, Anna-Katharina Heidenreich, Gestur Vidarsson, Dietmar Reusch, Markus Haberger, Manfred Wuhrer & David Falck. (2019) Glycoform-resolved FcɣRIIIa affinity chromatography–mass spectrometry. mAbs 11:7, pages 1191-1196.
Read now
Read now
Hélène Kaplon & Janice M. Reichert. (2019) Antibodies to watch in 2019. mAbs 11:2, pages 219-238.
Read now
Read now
Natasha A. Pereira, Kah Fai Chan, Pao Chun Lin & Zhiwei Song. (2018) The “less-is-more” in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity. mAbs 10:5, pages 693-711.
Read now
Read now
Nathalie Fournier, Emilie Jacque, Alexandre Fontayne, Delphine Derache, Gilles Dupont, Lucie Verhaeghe, Linda Baptista, Aurélie Dehenne, Anne-Sophie Dezetter, Aurélie Terrier, Alain Longue, Virginie Pochet-Beghin, Cecile Beghin, Sami Chtourou & Christophe de Romeuf. (2018) Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern. mAbs 10:4, pages 651-663.
Read now
Read now
Alexandre Ambrogelly, Stephen Gozo, Amit Katiyar, Shara Dellatore, Yune Kune, Ram Bhat, Joanne Sun, Ning Li, Dongdong Wang, Christine Nowak, Alyssa Neill, Gomathinayagam Ponniah, Cory King, Bruce Mason, Alain Beck & Hongcheng Liu. (2018) Analytical comparability study of recombinant monoclonal antibody therapeutics. mAbs 10:4, pages 513-538.
Read now
Read now
Patrick J. Kennedy, Carla Oliveira, Pedro L. Granja & Bruno Sarmento. (2018) Monoclonal antibodies: technologies for early discovery and engineering. Critical Reviews in Biotechnology 38:3, pages 394-408.
Read now
Read now
Mohammed Akli Ayoub, Pascale Crépieux, Markus Koglin, Marc Parmentier, Jean-Philippe Pin, Anne Poupon, Eric Reiter, Martine Smit, Jan Steyaert, Hervé Watier & Trevor Wilkinson. (2017) Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challenges. mAbs 9:5, pages 735-741.
Read now
Read now
Janice M. Reichert. (2017) Antibodies to watch in 2017. mAbs 9:2, pages 167-181.
Read now
Read now
Jenny Calow, Anna-Janina Behrens, Sonja Mader, Ulrike Bockau, Weston B. Struwe, David J. Harvey, Kai U. Cormann, Marc M. Nowaczyk, Karin Loser, Daniel Schinor, Marcus W.W. Hartmann & Max Crispin. (2016) Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity. mAbs 8:8, pages 1498-1511.
Read now
Read now
Jun Hasegawa, Mayumi Sue, Michiko Yamato, Junya Ichikawa, Saori Ishida, Tomoko Shibutani, Michiko Kitamura, Teiji Wada & Toshinori Agatsuma. (2016) Novel anti-EPHA2 antibody, DS-8895a for cancer treatment. Cancer Biology & Therapy 17:11, pages 1158-1167.
Read now
Read now
Jing Fang, Catalin Doneanu, William R. Alley$suffix/text()$suffix/text(), Ying Qing Yu, Alain Beck & Weibin Chen. (2016) Advanced assessment of the physicochemical characteristics of Remicade® and Inflectra® by sensitive LC/MS techniques. mAbs 8:6, pages 1021-1034.
Read now
Read now
Juergen M. Schanzer, Katharina Wartha, Ekkehard Moessner, Ralf J. Hosse, Samuel Moser, Rebecca Croasdale, Halina Trochanowska, Cuiying Shao, Peng Wang, Lei Shi, Tina Weinzierl, Natascha Rieder, Marina Bacac, Carola H. Ries, Hubert Kettenberger, Tilman Schlothauer, Thomas Friess, Pablo Umana & Christian Klein. (2016) XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer. mAbs 8:4, pages 811-827.
Read now
Read now
Lei Zhang, Shen Luo & Baolin Zhang. (2016) Glycan analysis of therapeutic glycoproteins. mAbs 8:2, pages 205-215.
Read now
Read now
Martina Dicker & Richard Strasser. (2015) Using glyco-engineering to produce therapeutic proteins. Expert Opinion on Biological Therapy 15:10, pages 1501-1516.
Read now
Read now
Rabah Gahoual, Michaël Biacchi, Johana Chicher, Lauriane Kuhn, Philippe Hammann, Alain Beck, Emmanuelle Leize-Wagner & Yannis N François. (2014) Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry. mAbs 6:6, pages 1464-1473.
Read now
Read now
Eric Ezan, François Becher & François Fenaille. (2014) Assessment of the metabolism of therapeutic proteins and antibodies. Expert Opinion on Drug Metabolism & Toxicology 10:8, pages 1079-1091.
Read now
Read now
James Edward Pease & Richard Horuk. (2014) Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4. Expert Opinion on Drug Discovery 9:5, pages 467-483.
Read now
Read now
Céline Monnet, Sylvie Jorieux, Nathalie Souyris, Ouafa Zaki, Alexandra Jacquet, Nathalie Fournier, Fabien Crozet, Christophe de Romeuf, Khalil Bouayadi, Rémi Urbain, Christian K Behrens, Philippe Mondon & Alexandre Fontayne. (2014) Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody. mAbs 6:2, pages 422-436.
Read now
Read now
Stefanie Derer, Pia Glorius, Martin Schlaeth, Stefan Lohse, Katja Klausz, Umesh Muchhal, John R Desjarlais, Andreas Humpe, Thomas Valerius & Matthias Peipp. (2014) Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity. mAbs 6:2, pages 409-421.
Read now
Read now
Patrick M Buck, Sandeep Kumar & Satish K Singh. (2013) Consequences of glycan truncation on Fc structural integrity. mAbs 5:6, pages 904-916.
Read now
Read now
Alain Beck, Paul J. Carter, Hans-Peter Gerber, Alexey A. Lugovskoy, Thierry Wurch, Jagath R. Junutula, Roland E Kontermann & Robert Mabry. (2013) 8th Annual European Antibody Congress 2012. mAbs 5:3, pages 339-357.
Read now
Read now
Rabah Gahoual, Alicia Burr, Jean-Marc Busnel, Lauriane Kuhn, Phillipe Hammann, Alain Beck, Yannis-Nicolas François & Emmanuelle Leize-Wagner. (2013) Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry. mAbs 5:3, pages 479-490.
Read now
Read now
Paul J Declerck. (2013) Biosimilar monoclonal antibodies: a science-based regulatory challenge. Expert Opinion on Biological Therapy 13:2, pages 153-156.
Read now
Read now
Articles from other publishers (152)
Yosra Helali, Axelle Bourez, Arnaud Marchant, Yvan Vander Heyden, Pierre Van Antwerpen & Cedric Delporte. (2023) Development and validation of online SPE purification coupled to HILIC-fluorescence-MS analysis for the characterization of N-glycans. Talanta, pages 125541.
Crossref
Crossref
Eduardo F. Mufarrege, Lucía C. Peña & Marina Etcheverrigaray. 2023. Antiviral Strategies in the Treatment of Human and Animal Viral Infections [Working Title]. Antiviral Strategies in the Treatment of Human and Animal Viral Infections [Working Title].
Matteo Paccagnella, Andrea Abbona, Nerina Denaro, Marco Merlano & Ornella Garrone. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
21
.
Sachin S. Shivatare, Vidya S. Shivatare & Chi-Huey Wong. (2022) Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments. Chemical Reviews 122:20, pages 15603-15671.
Crossref
Crossref
Benjamin Samuel Haslund-Gourley, Stéphane Grauzam, Anand S. Mehta, Brian Wigdahl & Mary Ann Comunale. (2022) Acute Lyme disease IgG N-linked glycans contrast the canonical inflammatory signature. Frontiers in Immunology 13.
Crossref
Crossref
Toshihiko Tashima. (2022) Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody Conjugates. Biomedicines 10:7, pages 1597.
Crossref
Crossref
Babette Wolf, Mateusz Piksa, Isabelle Beley, Agnes Patoux, Thierry Besson, Valerie Cordier, Bernd Voedisch, Patrick Schindler, Daniela Stöllner, Ludovic Perrot, Stephan von Gunten, Dominique Brees & Michael Kammüller. (2022) Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity. Immunology 166:3, pages 380-407.
Crossref
Crossref
Josée Golay, Alain E. Andrea & Irene Cattaneo. (2022) Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies. Frontiers in Immunology 13.
Crossref
Crossref
Eleonora Nicolò, Federica Giugliano, Liliana Ascione, Paolo Tarantino, Chiara Corti, Sara M. Tolaney, Massimo Cristofanilli & Giuseppe Curigliano. (2022) Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives. Cancer Treatment Reviews 106, pages 102395.
Crossref
Crossref
Yoichi Shimizu, Sho Koyasu, Mari Suzukida, Kiyotaka Izumi, Eitaro Kidera, Takero Shindo, Tsuneo Saga, Masahiro Ono, Akifumi Takaori-Kondo & Yuji Nakamoto. (2022) Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo. Annals of Nuclear Medicine 36:3, pages 319-326.
Crossref
Crossref
Georgina To'a Salazar, Ziyi Huang, Ningyan Zhang, Xue-Guang Zhang & Zhiqiang An. (2021) Antibody Therapies Targeting Complex Membrane Proteins. Engineering 7:11, pages 1541-1551.
Crossref
Crossref
Bastiaan L. Duivelshof, Steffy Denorme, Koen Sandra, Xiaoxiao Liu, Alain Beck, Matthew A. Lauber, Davy Guillarme & Valentina D’Atri. (2021) Quantitative N-Glycan Profiling of Therapeutic Monoclonal Antibodies Performed by Middle-Up Level HILIC-HRMS Analysis. Pharmaceutics 13:11, pages 1744.
Crossref
Crossref
Kristina Zlatina & Sebastian P. Galuska. (2021) Immunoglobulin Glycosylation – An Unexploited Potential for Immunomodulatory Strategies in Farm Animals. Frontiers in Immunology 12.
Crossref
Crossref
Patricia Gogesch, Simone Dudek, Ger van Zandbergen, Zoe Waibler & Martina Anzaghe. (2021) The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies. International Journal of Molecular Sciences 22:16, pages 8947.
Crossref
Crossref
Khaled Alhosaini, Asim Azhar, Asma Alonazi & F Al-Zoghaibi. (2021) GPCRs: The most promiscuous druggable receptor of the mankind. Saudi Pharmaceutical Journal 29:6, pages 539-551.
Crossref
Crossref
Eline A. M. Zijtregtop, Iris van der Strate, Auke Beishuizen, Christian M. Zwaan, Marijn A. Scheijde-Vermeulen, Arianne M. Brandsma & Friederike Meyer-Wentrup. (2021) Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma. Cancers 13:4, pages 884.
Crossref
Crossref
Evan Rossignol, Galit Alter & Boris Julg. (2021) Antibodies for Human Immunodeficiency Virus-1 Cure Strategies. The Journal of Infectious Diseases 223:Supplement_1, pages S22-S31.
Crossref
Crossref
N Vukovic, A van Elsas, J S Verbeek & D M W Zaiss. (2021) Isotype selection for antibody-based cancer therapy. Clinical and Experimental Immunology 203:3, pages 351-365.
Crossref
Crossref
Kayla Bastian, Emma Scott, David J. Elliott & Jennifer Munkley. (2021) FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer. International Journal of Molecular Sciences 22:1, pages 455.
Crossref
Crossref
雪玲 居. (2021) Discussion on Characterization and Quality Control Strategies of Antibody N-Glycosylation. Pharmacy Information 10:03, pages 85-91.
Crossref
Crossref
Boris Julg & Dan Barouch. (2021) Broadly neutralizing antibodies for HIV-1 prevention and therapy. Seminars in Immunology 51, pages 101475.
Crossref
Crossref
Itzcóatl Gómez Aquino & Ioscani Jiménez del Val. 2021. Cell Culture Engineering and Technology. Cell Culture Engineering and Technology
147
188
.
Josiane Saadé, Michael Biacchi, Jérémie Giorgetti, Antony Lechner, Alain Beck, Emmanuelle Leize-Wagner & Yannis-Nicolas François. 2021. Mass Spectrometry of Glycoproteins. Mass Spectrometry of Glycoproteins
97
106
.
Elsa Wagner-Rousset, Olivier Colas, Stéphane Chenu, Yannis-Nicolas François, Davy Guillarme, Sarah Cianferani, Yury O. Tsybin, Jonathan Sjögren, Arnaud Delobel & Alain Beck. 2021. Mass Spectrometry of Glycoproteins. Mass Spectrometry of Glycoproteins
73
83
.
Arnaud Delobel. 2021. Mass Spectrometry of Glycoproteins. Mass Spectrometry of Glycoproteins
1
21
.
Emmanuel Margolin, Max Crispin, Ann Meyers, Ros Chapman & Edward P. Rybicki. (2020) A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding. Frontiers in Plant Science 11.
Crossref
Crossref
Bo Ma, Xiaoyang Guan, Yaohao Li, Shiying Shang, Jing Li & Zhongping Tan. (2020) Protein Glycoengineering: An Approach for Improving Protein Properties. Frontiers in Chemistry 8.
Crossref
Crossref
Maxim Soroko & David H. Kwan. (2020) Enzymatic Synthesis of a Fluorogenic Reporter Substrate and the Development of a High-Throughput Assay for Fucosyltransferase VIII Provide a Toolkit to Probe and Inhibit Core Fucosylation. Biochemistry 59:22, pages 2100-2110.
Crossref
Crossref
Corina Duda-Seiman, Daniel Duda-Seiman & Mihai V. Putz. 2020. New Frontiers in Nanochemistry. New Frontiers in Nanochemistry
381
386
.
Jonathan Sjögren, Rolf Lood & Andreas Nägeli. (2020) On enzymatic remodeling of IgG glycosylation; unique tools with broad applications. Glycobiology 30:4, pages 254-267.
Crossref
Crossref
Marta Ząbczyńska, Katarzyna Polak, Kamila Kozłowska, Grzegorz Sokołowski & Ewa Pocheć. (2020) The Contribution of IgG Glycosylation to Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC) in Hashimoto’s Thyroiditis: An in Vitro Model of Thyroid Autoimmunity. Biomolecules 10:2, pages 171.
Crossref
Crossref
Jonathan Hurtado, Dhiraj Acharya, Huafang Lai, Haiyan Sun, Somanath Kallolimath, Herta Steinkellner, Fengwei Bai & Qiang Chen. (2019)
In vitro and in vivo
efficacy of anti‐chikungunya virus monoclonal antibodies produced in wild‐type and glycoengineered
Nicotiana benthamiana
plants
. Plant Biotechnology Journal 18:1, pages 266-273.
Crossref
Crossref
Surinder M. Soond & Andrey A. ZamyatninJr.Jr.. 2020. GPCR Signaling in Cancer. GPCR Signaling in Cancer
49
97
.
Jinze Li, Mayur S. Mitra & Gautham K. Rao. 2020. Immuno-Oncology. Immuno-Oncology
199
238
.
Thomas Rexer, Dominic Laaf, Johannes Gottschalk, Hannes Frohnmeyer, Erdmann Rapp & Lothar Elling. 2021. Advances in Glycobiotechnology. Advances in Glycobiotechnology
231
280
.
Yuki Yagi, Akira Okazaki, Megumi Endo, Kumi Yanagisawa, Jun Fukuda, Koichiro Nishimura & Katsuyoshi Yamazaki. (2019) A Comparison of the Oligosaccharide Structures of Antithrombin Derived from Plasma and Recombinant Using POTELLIGENT® Technology. Analytical Sciences 35:12, pages 1333-1340.
Crossref
Crossref
Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard & Martine J. Smit. (2019) Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3. Molecular Pharmacology 96:6, pages 753-764.
Crossref
Crossref
Steffen Lippold, Simone Nicolardi, Manfred Wuhrer & David Falck. (2019) Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry of Fc Moieties. Frontiers in Chemistry 7.
Crossref
Crossref
Kuhne, Bonnington, Malik, Thomann, Avenal, Wegele, Reusch, Mormann, Bulau & Cymer. (2019) The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange. Antibodies 8:4, pages 49.
Crossref
Crossref
Marloes Grobben, Richard AL Stuart & Marit J van Gils. (2019) The potential of engineered antibodies for HIV-1 therapy and cure. Current Opinion in Virology 38, pages 70-80.
Crossref
Crossref
Fatemeh Yarian, Abbas Alibakhshi, Shirin Eyvazi, Roghaye Arezumand & Shahrzad Ahangarzadeh. (2019) Antibody‐drug therapeutic conjugates: Potential of antibody‐siRNAs in cancer therapy. Journal of Cellular Physiology 234:10, pages 16724-16738.
Crossref
Crossref
Polina Weitzenfeld, Stylianos Bournazos & Jeffrey V. Ravetch. (2019) Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways. Journal of Clinical Investigation 129:9, pages 3952-3962.
Crossref
Crossref
Kevin O. Saunders. (2019) Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life. Frontiers in Immunology 10.
Crossref
Crossref
David Brühlmann, Thomas Vuillemin, Abhijeet Satwekar, Eugenio Galano, Angelo Palmese, Alessandra D'Angelo, Zeynep Manco, Jonathan Souquet, Hervé Broly, Markus Sauer, Jürgen Hemberger & Martin Jordan. (2019) Generation of site‐distinct N‐glycan variants for in vitro bioactivity testing. Biotechnology and Bioengineering 116:5, pages 1017-1028.
Crossref
Crossref
Mouldy Sioud. (2019) Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics. Molecular Biotechnology 61:4, pages 286-303.
Crossref
Crossref
Renato Mastrangeli, Wolf Palinsky & Horst Bierau. (2019) Glycoengineered antibodies: towards the next-generation of immunotherapeutics. Glycobiology 29:3, pages 199-210.
Crossref
Crossref
Mariana Lopes dos Santos, Wagner Quintilio, Tania Maria Manieri, Lilian Rumi Tsuruta & Ana Maria Moro. (2018) Advances and challenges in therapeutic monoclonal antibodies drug development. Brazilian Journal of Pharmaceutical Sciences 54:spe.
Crossref
Crossref
Erica Ollmann Saphire, Sharon L. Schendel, Bronwyn M. Gunn, Jacob C. Milligan & Galit Alter. (2018) Antibody-mediated protection against Ebola virus. Nature Immunology 19:11, pages 1169-1178.
Crossref
Crossref
Kaname Muchima, Taro Todaka, Hiroyuki Shinchi, Ayaka Sato, Arisa Tazoe, Rikiya Aramaki, Yuhei Kakitsubata, Risa Yokoyama, Naomichi Arima, Masanori Baba, Masahiro Wakao, Yuji Ito & Yasuo Suda. (2018) Development of sugar chain-binding single-chain variable fragment antibody to adult T-cell leukemia cells using glyco-nanotechnology and phage display method. The Journal of Biochemistry 163:4, pages 281-291.
Crossref
Crossref
Gillian Dekkers, Theo Rispens & Gestur Vidarsson. (2018) Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases. Frontiers in Immunology 9.
Crossref
Crossref
Paul J. Carter & Greg A. Lazar. (2017) Next generation antibody drugs: pursuit of the 'high-hanging fruit'. Nature Reviews Drug Discovery 17:3, pages 197-223.
Crossref
Crossref
Noritaka Hashii & Akiko Ishii-Watabe. (2018) Quality characterization of biological products by mass spectrometry質量分析によるバイオ医薬品の品質特性解析. Electrophoresis Letters 62:1, pages 31-37.
Crossref
Crossref
Andreas Castan, Patrick Schulz, Till Wenger & Simon Fischer. 2018. Biopharmaceutical Processing. Biopharmaceutical Processing
131
146
.
Günter Jagschies. 2018. Biopharmaceutical Processing. Biopharmaceutical Processing
59
72
.
Xinhua Wang, Mary Mathieu & Randall J. Brezski. (2017) IgG Fc engineering to modulate antibody effector functions. Protein & Cell 9:1, pages 63-73.
Crossref
Crossref
Chao Li, Tiezheng Li & Lai-Xi Wang. 2018. Antibody Engineering. Antibody Engineering
367
380
.
Amanda Mizukami, Angelo Luis Caron, Virgínia Picanço-Castro & Kamilla Swiech. 2018. Recombinant Glycoprotein Production. Recombinant Glycoprotein Production
1
14
.
Charlot De Wachter, Linde Van Landuyt & Nico Callewaert. 2021. Advances in Glycobiotechnology. Advances in Glycobiotechnology
93
135
.
Zehra Elgundi, Mouhamad Reslan, Esteban Cruz, Vicki Sifniotis & Veysel Kayser. (2017) The state-of-play and future of antibody therapeutics. Advanced Drug Delivery Reviews 122, pages 2-19.
Crossref
Crossref
Hervé Watier & Janice M. Reichert. 2017. Protein Therapeutics. Protein Therapeutics
25
49
.
Katja Klausz, Michael Cieker, Christian Kellner, Hans-Heinrich Oberg, Dieter Kabelitz, Thomas Valerius, Renate Burger, Martin Gramatzki & Matthias Peipp. (2017) A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries. Oncotarget 8:44, pages 77552-77566.
Crossref
Crossref
Kristina M. Ilieva, Judit Fazekas-Singer, Daniela Y. Achkova, Tihomir S. Dodev, Silvia Mele, Silvia Crescioli, Heather J. Bax, Anthony Cheung, Panagiotis Karagiannis, Isabel Correa, Mariangela Figini, Rebecca Marlow, Debra H. Josephs, Andrew J. Beavil, John Maher, James F. Spicer, Erika Jensen-Jarolim, Andrew N. Tutt & Sophia N. Karagiannis. (2017) Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields. Frontiers in Immunology 8.
Crossref
Crossref
Pei Xiong Liew, Jung Hwan Kim, Woo-Yong Lee & Paul Kubes. (2017) Antibody-dependent fragmentation is a newly identified mechanism of cell killing in vivo. Scientific Reports 7:1.
Crossref
Crossref
Sofia Järnum, Anna Runström, Robert Bockermann, Lena Winstedt, Max Crispin & Christian Kjellman. (2017) Enzymatic Inactivation of Endogenous IgG by IdeS Enhances Therapeutic Antibody Efficacy. Molecular Cancer Therapeutics 16:9, pages 1887-1897.
Crossref
Crossref
Yubo Tang, Feng Tang, Yang Yang, Lei Zhao, Hu Zhou, Jinhua Dong & Wei Huang. (2017) Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control. Scientific Reports 7:1.
Crossref
Crossref
Gillian Dekkers, Louise Treffers, Rosina Plomp, Arthur E. H. Bentlage, Marcella de Boer, Carolien A. M. Koeleman, Suzanne N. Lissenberg-Thunnissen, Remco Visser, Mieke Brouwer, Juk Yee Mok, Hanke Matlung, Timo K. van den Berg, Wim J. E. van Esch, Taco W. Kuijpers, Diana Wouters, Theo Rispens, Manfred Wuhrer & Gestur Vidarsson. (2017) Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities. Frontiers in Immunology 8.
Crossref
Crossref
Feng Tang, Lai-Xi Wang & Wei Huang. (2017) Chemoenzymatic synthesis of glycoengineered IgG antibodies and glycosite-specific antibody–drug conjugates. Nature Protocols 12:8, pages 1702-1721.
Crossref
Crossref
Minoru Tada & Akiko Ishii-Watabe. (2017) Characterization of Therapeutic Monoclonal Antibodies by Using FcγR-expressing Reporter Cell LinesFcγ受容体発現レポーター細胞を用いた抗体医薬品の品質評価. YAKUGAKU ZASSHI 137:7, pages 837-843.
Crossref
Crossref
Masato Kiyoshi, Kouhei Tsumoto, Akiko Ishii-Watabe & Jose M M Caaveiro. (2017) Glycosylation of IgG-Fc: a molecular perspective. International Immunology 29:7, pages 311-317.
Crossref
Crossref
Huifang Zong, Lei Han, Kai Ding, Jiaxian Wang, Tao Sun, Xinyu Zhang, Cedric Cagliero, Hua Jiang, Yueqing Xie, Jianrong Xu, Baohong Zhang & Jianwei Zhu. (2017)
Producing defucosylated antibodies with enhanced in vitro antibody-dependent cellular cytotoxicity via
FUT8
knockout CHO-S cells
. Engineering in Life Sciences 17:7, pages 801-808.
Crossref
Crossref
Weilai Guo, Feng Tang, Ken Qin, Mang Zhou, Zhiping Le & Wei Huang. (2017) Glycoengineering and glycosite-specific labeling of serum IgGs from various species. Carbohydrate Research 446-447, pages 32-39.
Crossref
Crossref
Alain Beck, Liliane Goetsch, Charles Dumontet & Nathalie Corvaïa. (2017) Strategies and challenges for the next generation of antibody–drug conjugates. Nature Reviews Drug Discovery 16:5, pages 315-337.
Crossref
Crossref
Eric Largy, Fabrice Cantais, Géry Van Vyncht, Alain Beck & Arnaud Delobel. (2017) Orthogonal liquid chromatography–mass spectrometry methods for the comprehensive characterization of therapeutic glycoproteins, from released glycans to intact protein level. Journal of Chromatography A 1498, pages 128-146.
Crossref
Crossref
Valentina D’Atri, Szabolcs Fekete, Alain Beck, Matthew Lauber & Davy Guillarme. (2017) Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis. Analytical Chemistry 89:3, pages 2086-2092.
Crossref
Crossref
Chiara Berlato, Moddasar N. Khan, Tiziana Schioppa, Richard Thompson, Eleni Maniati, Anne Montfort, Maryam Jangani, Monica Canosa, Hagen Kulbe, Urs B. Hagemann, Alexander R. Duncan, Laura Fletcher, Robert W. Wilkinson, Thomas Powles, Sergio A. Quezada & Frances R. Balkwill. (2017) A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. Journal of Clinical Investigation 127:3, pages 801-813.
Crossref
Crossref
Christian Kellner, Anna Otte, Elisa Cappuzzello, Katja Klausz & Matthias Peipp. (2017) Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy. Transfusion Medicine and Hemotherapy 44:5, pages 327-336.
Crossref
Crossref
Roy Jefferis. 2016. Biosimilars of Monoclonal Antibodies. Biosimilars of Monoclonal Antibodies
155
199
.
M. V. Padkina & E. V. Sambuk. (2016) Genetically modified microorganisms as producers of biologically active compounds. Russian Journal of Genetics: Applied Research 6:6, pages 669-683.
Crossref
Crossref
Hye In Park, Hyun Woung Yoon & Sang Taek Jung. (2016) The Highly Evolvable Antibody Fc Domain. Trends in Biotechnology 34:11, pages 895-908.
Crossref
Crossref
Rosie Upton, Leonard Bell, Colin Guy, Paul Caldwell, Sian Estdale, Perdita E. Barran & David Firth. (2016) Orthogonal Assessment of Biotherapeutic Glycosylation: A Case Study Correlating N-Glycan Core Afucosylation of Herceptin with Mechanism of Action. Analytical Chemistry 88:20, pages 10259-10265.
Crossref
Crossref
Austin WT Chiang, Shangzhong Li, Philipp N Spahn, Anne Richelle, Chih-Chung Kuo, Mojtaba Samoudi & Nathan E Lewis. (2016) Modulating carbohydrate–protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology. Current Opinion in Structural Biology 40, pages 104-111.
Crossref
Crossref
Dwight Stoll, John Danforth, Kelly Zhang & Alain Beck. (2016) Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detection. Journal of Chromatography B 1032, pages 51-60.
Crossref
Crossref
Rabah Gahoual, Alain Beck, Emmanuelle Leize-Wagner & Yannis-Nicolas François. (2016) Cutting-edge capillary electrophoresis characterization of monoclonal antibodies and related products. Journal of Chromatography B 1032, pages 61-78.
Crossref
Crossref
Dominique T. Monteil, Valentin Juvet, Jonathan Paz, Marc Moniatte, Lucia Baldi, David L. Hacker & Florian M. Wurm. (2016) A comparison of orbitally-shaken and stirred-tank bioreactors: pH modulation and bioreactor type affect CHO cell growth and protein glycosylation. Biotechnology Progress 32:5, pages 1174-1180.
Crossref
Crossref
Ngoc Phuong Lan Le, Thomas A. Bowden, Weston B. Struwe & Max Crispin. (2016) Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:8, pages 1655-1668.
Crossref
Crossref
Tomas Bertok, Erika Dosekova, Stefan Belicky, Alena Holazova, Lenka Lorencova, Danica Mislovicova, Darina Paprckova, Alica Vikartovska, Robert Plicka, Jan Krejci, Marketa Ilcikova, Peter Kasak & Jan Tkac. (2016) Mixed Zwitterion-Based Self-Assembled Monolayer Interface for Impedimetric Glycomic Analyses of Human IgG Samples in an Array Format. Langmuir 32:28, pages 7070-7078.
Crossref
Crossref
Peter Sondermann & David E Szymkowski. (2016) Harnessing Fc receptor biology in the design of therapeutic antibodies. Current Opinion in Immunology 40, pages 78-87.
Crossref
Crossref
Camille Perrin, Will Burkitt, Xavier Perraud, John O’Hara & Carl Jone. (2016) Limited proteolysis and peptide mapping for comparability of biopharmaceuticals: An evaluation of repeatability, intra-assay precision and capability to detect structural change. Journal of Pharmaceutical and Biomedical Analysis 123, pages 162-172.
Crossref
Crossref
Yuting Cong, Zhang Zhang, Shen Zhang, Lianghai Hu & Jingkai Gu. (2016) Quantitative MS analysis of therapeutic mAbs and their glycosylation for pharmacokinetics study. PROTEOMICS - Clinical Applications 10:4, pages 303-314.
Crossref
Crossref
Migyeong Jo & Sang Taek Jung. (2016) Engineering therapeutic antibodies targeting G-protein–coupled receptors. Experimental & Molecular Medicine 48:2, pages e207-e207.
Crossref
Crossref
Apurva S. More, Vishal M. Toprani, Solomon Z. Okbazghi, Jae H. Kim, Sangeeta B. Joshi, C. Russell Middaugh, Thomas J. Tolbert & David B. Volkin. (2016) Correlating the Impact of Well-Defined Oligosaccharide Structures on Physical Stability Profiles of IgG1-Fc Glycoforms. Journal of Pharmaceutical Sciences 105:2, pages 588-601.
Crossref
Crossref
Martina Dicker, Marc Tschofen, Daniel Maresch, Julia König, Paloma Juarez, Diego Orzaez, Friedrich Altmann, Herta Steinkellner & Richard Strasser. (2016) Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants. Frontiers in Plant Science 7.
Crossref
Crossref
Feng Tang, Yang Yang, Yubo Tang, Shuai Tang, Liyun Yang, Bingyang Sun, Bofeng Jiang, Jinhua Dong, Hong Liu, Min Huang, Mei-Yu Geng & Wei Huang. (2016) One-pot N-glycosylation remodeling of IgG with non-natural sialylglycopeptides enables glycosite-specific and dual-payload antibody–drug conjugates. Organic & Biomolecular Chemistry 14:40, pages 9501-9518.
Crossref
Crossref
Qi-Ying Hu, Francesco Berti & Roberto Adamo. (2016) Towards the next generation of biomedicines by site-selective conjugation. Chemical Society Reviews 45:6, pages 1691-1719.
Crossref
Crossref
Raymond H. de Wit, Sabrina M. de Munnik, Rob Leurs, Henry F. Vischer & Martine J. Smit. 2016. Chemokines. Chemokines
457
515
.
E. B. Struble, N. Kirschbaum, J. Liu, E. Marszal & M. Shapiro. 2017. Protein Therapeutics. Protein Therapeutics
69
121
.
Yuya Isoda, Hirokazu Yagi, Tadashi Satoh, Mami Shibata-Koyama, Kazuhiro Masuda, Mitsuo Satoh, Koichi Kato & Shigeru Iida. (2015) Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors. PLOS ONE 10:10, pages e0140120.
Crossref
Crossref
Gaëtan Vanier, Franziska Hempel, Philippe Chan, Michael Rodamer, David Vaudry, Uwe G. Maier, Patrice Lerouge & Muriel Bardor. (2015) Biochemical Characterization of Human Anti-Hepatitis B Monoclonal Antibody Produced in the Microalgae Phaeodactylum tricornutum. PLOS ONE 10:10, pages e0139282.
Crossref
Crossref
Jonathan Sjögren, Eoin F J Cosgrave, Maria Allhorn, Maria Nordgren, Stephan Björk, Fredrik Olsson, Sarah Fredriksson & Mattias Collin. (2015) EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans. Glycobiology 25:10, pages 1053-1063.
Crossref
Crossref
Jennifer D. Könitzer, Markus M. Müller, Germán Leparc, Martin Pauers, Jan Bechmann, Patrick Schulz, Jochen Schaub, Barbara Enenkel, Tobias Hildebrandt, Martin Hampel & Anne B. Tolstrup. (2015) A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation. Biotechnology Journal 10:9, pages 1412-1423.
Crossref
Crossref
O. Boyman, C. Kaegi, M. Akdis, S. Bavbek, A. Bossios, A. Chatzipetrou, T. Eiwegger, D. Firinu, T. Harr, E. Knol, A. Matucci, O. Palomares, C. Schmidt-Weber, H.-U. Simon, U. C. Steiner, A. Vultaggio, C. A. Akdis & F. Spertini. (2015) EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy 70:7, pages 727-754.
Crossref
Crossref
Fernando Gomollón. (2015) Biosimilars in inflammatory bowel disease. Current Opinion in Gastroenterology 31:4, pages 290-295.
Crossref
Crossref
Gang Liu & Sriram Neelamegham. (2015) Integration of systems glycobiology with bioinformatics toolboxes, glycoinformatics resources, and glycoproteomics data. WIREs Systems Biology and Medicine 7:4, pages 163-181.
Crossref
Crossref
Tomas Bertok, Alena Šedivá, Jaroslav Filip, Marketa Ilcikova, Peter Kasak, Dusan Velic, Eduard Jane, Martina Mravcová, Jozef Rovenský, Pavol Kunzo, Peter Lobotka, Vasilij Šmatko, Alica Vikartovská & Jan Tkac. (2015) Carboxybetaine Modified Interface for Electrochemical Glycoprofiling of Antibodies Isolated from Human Serum. Langmuir 31:25, pages 7148-7157.
Crossref
Crossref
Marina Vladimirovna Padkina & Elena Viktorovna Sambuk. (2015) Genetically modified microorganisms as producers of biologically active compounds. Ecological genetics 13:2, pages 36-57.
Crossref
Crossref
Liming Liu. (2015) Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins. Journal of Pharmaceutical Sciences 104:6, pages 1866-1884.
Crossref
Crossref
David Brühlmann, Martin Jordan, Jürgen Hemberger, Markus Sauer, Matthieu Stettler & Hervé Broly. (2015) Tailoring recombinant protein quality by rational media design. Biotechnology Progress 31:3, pages 615-629.
Crossref
Crossref
Alison J. Smith. (2015) New Horizons in Therapeutic Antibody Discovery: Opportunities and Challenges versus Small-Molecule Therapeutics. SLAS Discovery 20:4, pages 437-453.
Crossref
Crossref
Emil Paleček, Jan Tkáč, Martin Bartošík, Tomáš Bertók, Veronika Ostatná & Jan Paleček. (2015) Electrochemistry of Nonconjugated Proteins and Glycoproteins. Toward Sensors for Biomedicine and Glycomics. Chemical Reviews 115:5, pages 2045-2108.
Crossref
Crossref
Rinpei Niwa & Mitsuo Satoh. (2015) The Current Status and Prospects of Antibody Engineering for Therapeutic Use: Focus on Glycoengineering Technology. Journal of Pharmaceutical Sciences 104:3, pages 930-941.
Crossref
Crossref
Céline Monnet, Sylvie Jorieux, Rémi Urbain, Nathalie Fournier, Khalil Bouayadi, Christophe De Romeuf, Christian K. Behrens, Alexandre Fontayne & Philippe Mondon. (2015) Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions. Frontiers in Immunology 6.
Crossref
Crossref
Scot D. Liu, Cecile Chalouni, Judy C. Young, Teemu T. Junttila, Mark X. Sliwkowski & John B. Lowe. (2015) Afucosylated Antibodies Increase Activation of FcγRIIIa-Dependent Signaling Components to Intensify Processes Promoting ADCC. Cancer Immunology Research 3:2, pages 173-183.
Crossref
Crossref
S M Deyev, E N Lebedenko, L E Petrovskaya, D A Dolgikh, A G Gabibov & M P Kirpichnikov. (2015) Man-made antibodies and immunoconjugates with desired properties: function optimization using structural engineering. Russian Chemical Reviews 84:1, pages 1-26.
Crossref
Crossref
Bram Laukens, Charlotte De Visscher & Nico Callewaert. (2015) Engineering yeast for producing human glycoproteins: where are we now?. Future Microbiology 10:1, pages 21-34.
Crossref
Crossref
Osamu Yoshie & Kouji Matsushima. (2015) CCR4 and its ligands: from bench to bedside. International Immunology 27:1, pages 11-20.
Crossref
Crossref
Justin M. Prien, Henning Stöckmann, Simone Albrecht, Silvia M. Martin, Matthew Varatta, Marsha Furtado, Stephen Hosselet, Meiyao Wang, Trina Formolo, Pauline M. Rudd & John E. Schiel. 2015. State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study. State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study
185
235
.
Randall J. Brezski. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
125
146
.
Maureen Spearman & Michael Butler. 2015. Animal Cell Culture. Animal Cell Culture
237
258
.
Bram Laukens, Charlot De Wachter & Nico Callewaert. 2015. Glyco-Engineering. Glyco-Engineering
103
122
.
Alexey A. Lugovskoy & Melissa L. Geddie. 2015. Biobetters. Biobetters
203
220
.
William Kelton, Nishant Mehta, Wissam Charab, Jiwon Lee, Chang-han Lee, Takaaki Kojima, Tae Hyun Kang & George Georgiou. (2014) IgGA: A “Cross-Isotype” Engineered Human Fc Antibody Domain that Displays Both IgG-like and IgA-like Effector Functions. Chemistry & Biology 21:12, pages 1603-1609.
Crossref
Crossref
Marcus Remer, Aymen Al-Shamkhani, Martin Glennie & Peter Johnson. (2014) Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas. Immunotherapy 6:11, pages 1187-1206.
Crossref
Crossref
Tadashi Ueda. (2014) Next-generation optimized biotherapeutics — A review and preclinical study. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1844:11, pages 2053-2057.
Crossref
Crossref
Roy Jefferis. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
171
200
.
Matthias Peipp, Stefanie Derer, Stefan Lohse, Christian Kellner & Thomas Valerius. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
141
170
.
Christian Klein, Marina Bacac, Pablo Umaña & Michael Wenger. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
1695
1732
.
Marjorie A. Shapiro, Patrick G. Swann & M. Stacey Ricci. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
1231
1262
.
Stefan Dübel & Janice M. Reichert. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
1
14
.
Urs B. Hagemann, Lavinia Gunnarsson, Sol?ne G?raudie, Ulrike Scheffler, Remko A. Griep, Herald Reiersen, Alexander R. Duncan & Sergej M. Kiprijanov. (2014) Fully Human Antagonistic Antibodies against CCR4 Potently Inhibit Cell Signaling and Chemotaxis. PLoS ONE 9:7, pages e103776.
Crossref
Crossref
Reshmi Parameswaran, Min Lim, Fei Fei, Hisham Abdel-Azim, Anna Arutyunyan, Isabelle Schiffer, Margaret E. McLaughlin, Hermann Gram, Heather Huet, John Groffen & Nora Heisterkamp. (2014) Effector-Mediated Eradication of Precursor B Acute Lymphoblastic Leukemia with a Novel Fc-Engineered Monoclonal Antibody Targeting the BAFF-R. Molecular Cancer Therapeutics 13:6, pages 1567-1577.
Crossref
Crossref
Azra Muji?-Deli?Raymond H. de Wit, Folkert Verkaar & Martine J. Smit. (2014) GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics. Trends in Pharmacological Sciences 35:5, pages 247-255.
Crossref
Crossref
Thomas Schirrmann, Miriam Steinwand, Xenia Wezler, Andre ten Haaf, Mehmet K. Tur & Stefan Barth. (2013) CD30 as a Therapeutic Target for Lymphoma. BioDrugs 28:2, pages 181-209.
Crossref
Crossref
Arvind Rajpal, Pavel Strop, Yik Andy Yeung, Javier Chaparro‐Riggers & Jaume Pons. 2014. Therapeutic Fc‐Fusion Proteins. Therapeutic Fc‐Fusion Proteins
1
44
.
Tomas Bertok, Alena Sediva, Alica Vikartovska & Jan Tkac. (2014) Comparison of the 2D and 3D Nanostructured Lectin-Based Biosensors for In Situ Detection of Sialic Acid on Glycoproteins. International Journal of Electrochemical Science 9:2, pages 890-900.
Crossref
Crossref
Joanne Bronson, Amelia Black, Murali Dhar, Bruce Ellsworth & J. Robert Merritt. 2014.
437
508
.
Roy Jefferis. 2014. Antibody Fc. Antibody Fc
297
316
.
Victor Raúl Gómez Román, Joseph C. Murray & Louis M. Weiner. 2014. Antibody Fc. Antibody Fc
1
27
.
Jan Tkac, Tomas Bertok, Jozef Nahalka & Peter Gemeiner. 2014. Lectins. Lectins
421
445
.
Helena Ryšlavá, Veronika Doubnerová, Daniel Kavan & Ondřej Vaněk. (2013) Effect of posttranslational modifications on enzyme function and assembly. Journal of Proteomics 92, pages 80-109.
Crossref
Crossref
Tomas Bertok, Ludmila Klukova, Alena Sediva, Peter Kasák, Vladislav Semak, Matej Micusik, Maria Omastova, Lucia Chovanová, Miroslav Vlček, Richard Imrich, Alica Vikartovska & Jan Tkac. (2013) Ultrasensitive Impedimetric Lectin Biosensors with Efficient Antifouling Properties Applied in Glycoprofiling of Human Serum Samples. Analytical Chemistry 85:15, pages 7324-7332.
Crossref
Crossref
Irene van den Broek, Wilfried M.A. Niessen & William D. van Dongen. (2013) Bioanalytical LC–MS/MS of protein-based biopharmaceuticals. Journal of Chromatography B 929, pages 161-179.
Crossref
Crossref
Nicole M. Okeley, Stephen C. Alley, Martha E. Anderson, Tamar E. Boursalian, Patrick J. Burke, Kim M. Emmerton, Scott C. Jeffrey, Kerry Klussman, Che-Leung Law, Django Sussman, Brian E. Toki, Lori Westendorf, Weiping Zeng, Xinqun Zhang, Dennis R. Benjamin & Peter D. Senter. (2013) Development of orally active inhibitors of protein and cellular fucosylation. Proceedings of the National Academy of Sciences 110:14, pages 5404-5409.
Crossref
Crossref
Steven CL Ho, Yen Wah Tong & Yuansheng Yang. (2013) Generation of monoclonal antibody-producing mammalian cell lines. Pharmaceutical Bioprocessing 1:1, pages 71-87.
Crossref
Crossref
Jay J. Listinsky, Gene P. Siegal & Catherine M. Listinsky. (2013) Glycoengineering in cancer therapeutics. Anti-Cancer Drugs 24:3, pages 219-227.
Crossref
Crossref
Xiaoling Wang, Sandeep Kumar, Patrick M. Buck & Satish K. Singh. (2013) Impact of deglycosylation and thermal stress on conformational stability of a full length murine igG2a monoclonal antibody: Observations from molecular dynamics simulations. Proteins: Structure, Function, and Bioinformatics 81:3, pages 443-460.
Crossref
Crossref
Alain Beck, Elsa Wagner-Rousset, Daniel Ayoub, Alain Van Dorsselaer & Sarah Sanglier-Cianférani. (2012) Characterization of Therapeutic Antibodies and Related Products. Analytical Chemistry 85:2, pages 715-736.
Crossref
Crossref
André Winkler, Markus Berger & Marc Ehlers. (2013) Anti-rhesus D prophylaxis in pregnant women is based on sialylated IgG antibodies. F1000Research 2, pages 169.
Crossref
Crossref
Bo Wang, Ashley C. Gucinski, David A. Keire, Lucinda F. Buhse & Michael T. Boyne II. (2013) Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry. The Analyst 138:10, pages 3058.
Crossref
Crossref
David R. Webb, Tracy M. Handel, Anke Kretz-Rommel & Raymond C. Stevens. (2013) Opportunities for functional selectivity in GPCR antibodies. Biochemical Pharmacology 85:2, pages 147-152.
Crossref
Crossref
Joanne Bronson, Amelia Black, T. G. Murali Dhar, Bruce A. Ellsworth & J. Robert Merritt. 2013.
471
546
.
Eryl Liddell. 2013. The Immunoassay Handbook. The Immunoassay Handbook
245
265
.
Michael J. Gramer. 2014. Mammalian Cell Cultures for Biologics Manufacturing. Mammalian Cell Cultures for Biologics Manufacturing
123
166
.